期刊
GENOMICS
卷 112, 期 6, 页码 4486-4504出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygeno.2020.08.003
关键词
COVID-19; Cheminformatics; Immuno-transcriptomics; Immune genes; Interactomics; Phytocompounds; Systems pharmacology
资金
- RUSA 2.0 [Policy (TN MultiGen), Dept of Edn, GoI] [F. 24-51/2014-U]
- DSTFIST [SR/FST/LSI-639/2015(C)]
- UGC-SAP [F.5-1/2018/DRS-II (SAP-II)]
- DST-PURSE [SR/PURSE Phase 2/38 (G)]
Understanding the immunological behavior of COVID-19 cases at molecular level is essential for therapeutic development. In this study, multi-omics and systems pharmacology analyses were performed to unravel the multi-targeted mechanisms of novel bioactives to combat COVID-19. Immuno-transcriptomic dataset of healthy controls and COVID-19 cases was retrieved from ArrayExpress. Phytocompounds from ethnobotanical plants were collected from PubChem. Differentially expressed 98 immune genes associated with COVID-19 were derived through NetworkAnalyst 3.0. Among 259 plant derived compounds, 154 compounds were targeting 13 COVID-19 immune genes involved in diverse signaling pathways. In addition, pharmacological properties of these phytocompounds were compared with COVID-19 drugs prescribed by WHO, and 25 novel phytocompounds were found to be more efficient with higher bioactive scores. The current study unravels the virogenomic signatures which can serve as therapeutic targets and identified phytocompounds with anti-COVID-19 efficacy. However, further experimental validation is essential to bring out these molecules as commercial drug candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据